The Trans Tasman Radiation Oncology Group (TROG) is a global leader in radiotherapy research. 1 in 2 cancer patients will benefit from radiotherapy and TROG is working hard on ways to continually improve their treatment.
All types of cancer, one treatment
Working with doctors and researchers mainly in Australia and New Zealand, TROG focuses on cancers that can be treated with radiotherapy such as breast, lung, prostate, skin, head and neck.
Cancer research, a team effort
Over 1,000 researchers and doctors have been involved in TROG research studies. Most studies require patients and so far over 13,200 people have volunteered to participate in more than 80 trials, helping our researchers improve cancer treatments.